Cargando…
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clinical pharmacology. One key challenge is that PK models constructed using data from one dosing regimen must predict PK data for different dosing regimen(s). We propose a deep learning approach based on neural or...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283337/ https://www.ncbi.nlm.nih.gov/pubmed/34308294 http://dx.doi.org/10.1016/j.isci.2021.102804 |
_version_ | 1783723179231936512 |
---|---|
author | Lu, James Deng, Kaiwen Zhang, Xinyuan Liu, Gengbo Guan, Yuanfang |
author_facet | Lu, James Deng, Kaiwen Zhang, Xinyuan Liu, Gengbo Guan, Yuanfang |
author_sort | Lu, James |
collection | PubMed |
description | Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clinical pharmacology. One key challenge is that PK models constructed using data from one dosing regimen must predict PK data for different dosing regimen(s). We propose a deep learning approach based on neural ordinary differential equations (neural-ODE) and tested its generalizability against a variety of alternative models. Specifically, we used the PK data from two different treatment regimens of trastuzumab emtansine. The models performed similarly when the training and the test sets come from the same dosing regimen. However, for predicting a new treatment regimen, the neural-ODE model showed substantially better performance. To date, neural-ODE is the most accurate PK model in predicting untested treatment regimens. This study represents the first time neural-ODE has been applied to PK modeling and the results suggest it is a widely applicable algorithm with the potential to impact future studies. |
format | Online Article Text |
id | pubmed-8283337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82833372021-07-22 Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens Lu, James Deng, Kaiwen Zhang, Xinyuan Liu, Gengbo Guan, Yuanfang iScience Article Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clinical pharmacology. One key challenge is that PK models constructed using data from one dosing regimen must predict PK data for different dosing regimen(s). We propose a deep learning approach based on neural ordinary differential equations (neural-ODE) and tested its generalizability against a variety of alternative models. Specifically, we used the PK data from two different treatment regimens of trastuzumab emtansine. The models performed similarly when the training and the test sets come from the same dosing regimen. However, for predicting a new treatment regimen, the neural-ODE model showed substantially better performance. To date, neural-ODE is the most accurate PK model in predicting untested treatment regimens. This study represents the first time neural-ODE has been applied to PK modeling and the results suggest it is a widely applicable algorithm with the potential to impact future studies. Elsevier 2021-06-30 /pmc/articles/PMC8283337/ /pubmed/34308294 http://dx.doi.org/10.1016/j.isci.2021.102804 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Lu, James Deng, Kaiwen Zhang, Xinyuan Liu, Gengbo Guan, Yuanfang Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
title | Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
title_full | Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
title_fullStr | Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
title_full_unstemmed | Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
title_short | Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
title_sort | neural-ode for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283337/ https://www.ncbi.nlm.nih.gov/pubmed/34308294 http://dx.doi.org/10.1016/j.isci.2021.102804 |
work_keys_str_mv | AT lujames neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens AT dengkaiwen neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens AT zhangxinyuan neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens AT liugengbo neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens AT guanyuanfang neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens |